|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||48.24 - 48.46|
|52 Week Range||36.81 - 50.24|
|PE Ratio (TTM)||11.71|
|Dividend & Yield||1.64 (3.46%)|
|1y Target Est||N/A|
Spectrum Pharmaceuticals, Inc. (SPPI) initiated the registrational phase III study of qapzola in patients with non-muscle invasive bladder cancer (NMIBC) as per the FDA's requirement.
Shire plc (SHPG) submitted a Marketing Authorization Application (MAA) for lifitegrast for the treatment of dry eye disease in Europe.
Sanofi (SNY), one of the world's largest pharmaceutical companies, reported operational growth of 5.5% to reach revenue of 8.7 billion euros in 2Q17.